Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Carotid-femoral Pulse Wave Velocity Assessment in MACE Risk Prediction in Coronary Patients
Session:
Painel 12 - Prevenção / Reabilitação Cardíaca 1
Speaker:
Margarida Temtem
Congress:
CPC 2020
Topic:
J. Preventive Cardiology
Theme:
28. Risk Factors and Prevention
Subtheme:
28.3 Secondary Prevention
Session Type:
Posters
FP Number:
---
Authors:
Margarida Temtem; Marco Serrão; Andreia Pereira; Marina Santos; Flávio Mendonça; Joao Adriano Sousa; Joel Monteiro; Ana Célia Sousa; Sónia Freitas; Eva Henriques; Carolina Freitas; Ilídio Ornelas; A. Drumond de Freitas; Roberto Palma dos Reis; Maria Isabel Mendonça
Abstract
<p><strong>Background:</strong> Carotid–femoral pulse wave velocity (PWV), a direct measure of aortic stiffness, has become increasingly important for cardiovascular (CV) risk estimation, particularly in coronary patients. In this way, PWV could be a potent predictor of major adverse cardiovascular events (MACE).The use of PWV’s measurement as a routine tool for clinical patient evaluation, providing better cardiovascular risk stratification, may help in therapeutic decision in secondary prevention.<br /> <strong>Purpose:</strong> The aim of our study is to estimate the impact of PWV value in MACE risk prediction in patients with the diagnosis of coronary artery disease.<br /> <strong>Material and Methods:</strong> The study included 1676 coronary patients with a mean age of 53.3±7.9 years, 78.6% (n=1318) were male. PWV was measured by tonometry, through an automatic device, the Complior. It was created 2 groups, one with PWV ≤10 m/s and another with PWV >10 m/s. This population was followed-up for a mean of 5.0±4.2 years for the primary endpoint of MACE occurrence (combined endpoint of cardiovascular death, acute myocardial infarction, stroke, need for myocardial revascularization and need for hospitalization of any cardiac cause).<br /> <strong>Results:</strong> During the follow-up of these 2 groups, MACE occurrence differed significantly. In the group with PWV ≤10m/s, 33% had MACE vs 39% of MACE in the group with PWV >10 m/s (p<0.05). Overall, the patients with PWV >10 m/s presented more MACE than those with PWV <10 m/s, with an odds ratio of 1.29 (p<0.05).<br /> <strong>Conclusion: </strong>Our results evidence that coronary patients with increased PWV levels have a higher probability of MACE, than those with lower PWV. These results reveal the predictive role of PWV measurement in the risk of MACE.<br /> The particular fact that these patients have a high CV risk, PWV is an important tool to guide our therapeutic strategy in secondary prevention.</p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site